SGLT2 Inhibitors May Lower Risk of Kidney Stones in Type 2 Diabetes Patients
Rates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidney stones, but some forms of treatment for this condition may also have the benefit…
Plant-Based Food Swaps and Heart Disease Risk
Could plant-based food swaps lower heart disease and type 2 diabetes risk? Research suggests that replacing animal-based foods with plant-based alternatives may significantly reduce the risk of heart disease and type 2 diabetes. The study published in BMC Medicine analyzed…
Tips for Reducing Chronic Inflammation
A recent study has found that 18% of British individuals report experiencing chronic inflammation, a condition characterized by slow, long-term inflammation lasting several months to years. The severity and effects of chronic inflammation can vary depending on the cause of…
Semaglutide: A Revolutionary GLP-1 Receptor Agonist
Semaglutide, an agonist of the glucagon-like peptide-1 (GLP-1) receptor, has been making waves in the field of experimental studies, with researchers touting it as a revolutionary compound. The modest 30 amino acid incretin hormone, GLP-1, has shown significant activity, particularly…
Doctor Michael Mosley Advocates for Omega 3 Supplements
Diet and wellbeing guru Doctor Michael Mosley has recently advocated for the use of Omega 3 supplements as a beneficial addition to one’s diet. In a post on his Instagram feed, Dr. Mosley highlighted the potential impact of Omega 3…
Diabetes Drug Shows Promise in Protecting Against Colorectal Cancer
A recent analysis by researchers in the US suggests that a drug commonly used to treat type 2 diabetes could also be effective in protecting against colorectal cancer (CRC). The drug, known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), has…